| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 9e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |